Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, August 6 '25)

Image
By G.M.

 




    Am J Respir Crit Care Med

  1. MATTHAY MA, Zhou H, Sarma A, Alipanah-Lechner N, et al
    Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT).
    Am J Respir Crit Care Med. 2025 Jul 29. doi: 10.1164/rccm.202411-2254.
    PubMed         Abstract available


    Ann Intern Med

  2. FELDMAN CH, Santacroce L, Bassett IV, Thaweethai T, et al
    Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort.
    Ann Intern Med. 2025 Jul 29. doi: 10.7326/ANNALS-24-01971.
    PubMed         Abstract available


    Antiviral Res

  3. PATEL D, De R, Azadi N, Lee S, et al
    Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis.
    Antiviral Res. 2025;241:106245.
    PubMed         Abstract available

  4. AL KRAD D, Stegmann KM, Dickmanns A, Kumar P, et al
    The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication.
    Antiviral Res. 2025 Jul 29:106247. doi: 10.1016/j.antiviral.2025.106247.
    PubMed         Abstract available


    Clin Infect Dis

  5. PONCE D, Westercamp M, Soto G, Lessa FC, et al
    COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020-2021).
    Clin Infect Dis. 2025 Jul 29:ciaf343. doi: 10.1093.
    PubMed         Abstract available

  6. HUNDIE GB, Ashengo TA, Stender SC, Abraha M, et al
    Assessing Coronavirus Disease 2019 Vaccination Uptake and Incident Infections Among Ethiopian Healthcare Workers, Addis Ababa-2022: Implications for Public Health Preparedness.
    Clin Infect Dis. 2025 Jul 29:ciaf341. doi: 10.1093.
    PubMed         Abstract available

  7. PARRA G, Lessa FC, Campelo E, Amorim Ramos TC, et al
    Incidence of and Risk Factors for SARS-CoV-2 Infection Among Vaccinated Healthcare Workers During Emergence of SARS-CoV-2 Gamma Variant in the Amazon Region, Brazil, 2021.
    Clin Infect Dis. 2025 Jul 30:ciaf339. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  8. MASI P, Lescroart M, Veinstein A, Desmedt L, et al
    Antifungal Concentrations in Mechanically Ventilated COVID-19 Patients With or Without ECMO: The CAPADOSE observational retrospective multicenter Study.
    Int J Infect Dis. 2025 Jul 25:107996. doi: 10.1016/j.ijid.2025.107996.
    PubMed         Abstract available


    J Infect

  9. MALLINSON PA, Dasi T, Banjara SK, Lieber J, et al
    Impact of distribution of facemasks on community incidence and outcomes of COVID-19: A cluster randomised trial in India.
    J Infect. 2025 Jul 23:106557. doi: 10.1016/j.jinf.2025.106557.
    PubMed         Abstract available

  10. CHRISTIANSEN CH, Sogaard KK, Dam-Dalgeir G, Dessau RB, et al
    Surveillance of invasive beta-haemolytic streptococci in Denmark, 2012 to 2023: A nationwide study.
    J Infect. 2025 Jul 24:106559. doi: 10.1016/j.jinf.2025.106559.
    PubMed         Abstract available


    J Med Virol

  11. LI Y, Zhao W, Xu Y, Yu P, et al
    Comparison Across Species: SARS-CoV-2 Infection Leads to More Significant Myopathological Changes in A Rhesus Monkey Model.
    J Med Virol. 2025;97:e70512.
    PubMed         Abstract available

  12. BIRD PW, Nazareth J, Gardener J, Mreh A, et al
    Norovirus Epidemiology 2017-2023: Before, During, and After the COVID-19 Pandemic.
    J Med Virol. 2025;97:e70528.
    PubMed        

  13. ZHENG S, Zhou W, Sun Y, Lu X, et al
    Impact of Nonpharmaceutical Interventions During the COVID-19 Pandemic on the Epidemiology and Seasonal Patterns of Acute Respiratory Infections in Children.
    J Med Virol. 2025;97:e70522.
    PubMed         Abstract available


    J Virol

  14. ZHAO Y, Guo G, Sun Y, Zhang M, et al
    Membrane protein CRISPR screen identifies RPSA as an essential host factor for porcine epidemic diarrhea virus replication.
    J Virol. 2025 Jul 30:e0064925. doi: 10.1128/jvi.00649.
    PubMed         Abstract available

  15. O'CONNOR JJ, Roy A, Khattabi R, Kerr C, et al
    Mutations differentially affecting the coronavirus Mac1 ADP-ribose binding and hydrolysis activities indicate that it promotes multiple stages of the viral replication cycle.
    J Virol. 2025 Jul 30:e0062325. doi: 10.1128/jvi.00623.
    PubMed         Abstract available


    JAMA

  16. BAKER LD, Espeland MA, Whitmer RA, Snyder HM, et al
    Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.
    JAMA. 2025 Jul 28:e2512923. doi: 10.1001/jama.2025.12923.
    PubMed         Abstract available

  17. RUBIN R
    SARS-CoV-2 Variants Challenge Surveillance Efforts and COVID-19 Vaccines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.12273.
    PubMed        


    Nature

  18. KOZLOV M
    'Sleeping' cancer cells in the lungs can be roused by COVID and flu.
    Nature. 2025 Jul 30. doi: 10.1038/d41586-025-02420.
    PubMed        

  19. SWANSON K, Wu W, Bulaong NL, Pak JE, et al
    The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies.
    Nature. 2025 Jul 29. doi: 10.1038/s41586-025-09442.
    PubMed         Abstract available

  20. CHIA SB, Johnson BJ, Hu J, Valenca-Pereira F, et al
    Respiratory viral infections awaken metastatic breast cancer cells in lungs.
    Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09332.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »